Global Eosinophilic Asthma Treatment Market Growth (Status and Outlook) 2026-2032

October 2026 | 99 pages | ID: GDE47E49C617EN
LP Information

Abstracts

The global Eosinophilic Asthma Treatment market size is predicted to grow from US$ 48126 million in 2025 to US$ 174426 million in 2032; it is expected to grow at a CAGR of 18.3% from 2026 to 2032.

Eosinophilic asthma treatment focuses on managing a severe subtype of asthma characterized by elevated levels of eosinophils, a type of white blood cell that contributes to inflammation in the airways. Traditional therapies, such as inhaled corticosteroids and bronchodilators, often prove insufficient for patients with this phenotype. Monoclonal antibodies such as mepolizumab, reslizumab, and benralizumab target interleukin-5 (IL-5) or its receptor, effectively reducing eosinophil levels and decreasing the frequency of exacerbations. The management strategy also includes identifying eosinophilic biomarkers through blood tests or sputum analysis to ensure accurate diagnosis and therapy alignment.

Eosinophilic asthma is a phenotype of asthma characterized by elevated airway eosinophilic inflammation, particularly prevalent in patients with moderate to severe and recurrent acute exacerbations. From a pharmaceutical market perspective, this field has historically relied primarily on inhaled corticosteroids, LABAs, and, when necessary, oral corticosteroids to control symptoms. In recent years, however, it has clearly entered a precision medicine phase centered on patient phenotype identification and targeted biologic therapy. This is driving the eosinophilic asthma market away from the traditional approach of "treating all asthma patients with similar pathways" towards stratified treatment based on characteristics such as eosinophil levels, FeNO, allergic status, history of acute exacerbations, and nasal polyps.

Biologics are becoming the most important driver of growth in the eosinophilic asthma market, with the IL-5/IL-5R? pathway remaining the most direct and mature core pathway. Mepolizumab and reslizumab reduce eosinophilic inflammation by inhibiting IL-5 signaling, while benralizumab targets IL-5R? and directly depletes eosinophils. Meanwhile, dupilumab blocks IL-4R?, reaching a broader range of Type 2 inflammation patients, while tezepelumab intervenes from the upstream TSLP pathway, showing therapeutic value in some severe asthma patients with low eosinophil counts. Therefore, future market competition will not simply be a competition between anti-IL-5 drugs, but will evolve into a patient-stratified competition among IL-5/IL-5R, IL-4/IL-13, TSLP, and next-generation dual-target drugs. Treatment selection will increasingly rely on precise biomarkers and companion diagnostic systems.

Report Scope

LPI (LP Information)' newest research report, the “Eosinophilic Asthma Treatment Industry Forecast” looks at past sales and reviews total world Eosinophilic Asthma Treatment sales in 2025, providing a comprehensive analysis by region and market sector of projected Eosinophilic Asthma Treatment sales for 2026 through 2032. With Eosinophilic Asthma Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Eosinophilic Asthma Treatment industry.

This Insight Report provides a comprehensive analysis of the global Eosinophilic Asthma Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Eosinophilic Asthma Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Eosinophilic Asthma Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Eosinophilic Asthma Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Eosinophilic Asthma Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Eosinophilic Asthma Treatment market by product type, application, key players and key regions and countries.

Market Segmentation

Segmentation by Type:

• Intravenous Infusion
• Subcutaneous Injection

Segmentation by Target:

• Anti-IL-5
• Anti-IL-5R?
• Anti-IL-4R?
• Anti-TSLP
• Others

Segmentation by Disease Severity:

• Severe Eosinophilic Asthma
• Moderate-to-Severe Eosinophilic Asthma
• Others

Segmentation by Application:

• Children
• Adults
• Teenagers

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AstraZeneca
• GSK
• Genentech (Roche Group) & Novartis
• Regeneron Pharmaceuticals & Sanofi
• Teva Pharmaceuticals
• Amgen
• Sunshine Guojian
• Hengrui Pharma

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Eosinophilic Asthma Treatment Market Size (2021-2032)
  2.1.2 Eosinophilic Asthma Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Eosinophilic Asthma Treatment by Country/Region (2021, 2025 & 2032)
2.2 Eosinophilic Asthma Treatment Segment by Type
  2.2.1 Intravenous Infusion
  2.2.2 Subcutaneous Injection
  2.2.3 Eosinophilic Asthma Treatment Market Size by Type
    2.2.3.1 Eosinophilic Asthma Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global Eosinophilic Asthma Treatment Market Size Market Share by Type (2021-2026)
2.3 Eosinophilic Asthma Treatment Segment by Target
  2.3.1 Anti-IL-5
  2.3.2 Anti-IL-5R?
  2.3.3 Anti-IL-4R?
  2.3.4 Anti-TSLP
  2.3.5 Others
  2.3.6 Eosinophilic Asthma Treatment Market Size by Target
    2.3.6.1 Eosinophilic Asthma Treatment Market Size CAGR by Target (2021 VS 2025 VS 2032)
    2.3.6.2 Global Eosinophilic Asthma Treatment Market Size Market Share by Target (2021-2026)
2.4 Eosinophilic Asthma Treatment Segment by Disease Severity
  2.4.1 Severe Eosinophilic Asthma
  2.4.2 Moderate-to-Severe Eosinophilic Asthma
  2.4.3 Others
  2.4.4 Eosinophilic Asthma Treatment Market Size by Disease Severity
    2.4.4.1 Eosinophilic Asthma Treatment Market Size CAGR by Disease Severity (2021 VS 2025 VS 2032)
    2.4.4.2 Global Eosinophilic Asthma Treatment Market Size Market Share by Disease Severity (2021-2026)
2.5 Eosinophilic Asthma Treatment Segment by Application
  2.5.1 Children
  2.5.2 Adults
  2.5.3 Teenagers
  2.5.4 Eosinophilic Asthma Treatment Market Size by Application
    2.5.4.1 Eosinophilic Asthma Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.5.4.2 Global Eosinophilic Asthma Treatment Market Size Market Share by Application (2021-2026)

3 EOSINOPHILIC ASTHMA TREATMENT MARKET SIZE BY PLAYER

3.1 Eosinophilic Asthma Treatment Market Size Market Share by Player
  3.1.1 Global Eosinophilic Asthma Treatment Revenue by Player (2021-2026)
  3.1.2 Global Eosinophilic Asthma Treatment Revenue Market Share by Player (2021-2026)
3.2 Global Eosinophilic Asthma Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 EOSINOPHILIC ASTHMA TREATMENT BY REGION

4.1 Eosinophilic Asthma Treatment Market Size by Region (2021-2026)
4.2 Global Eosinophilic Asthma Treatment Annual Revenue by Country/Region (2021-2026)
4.3 Americas Eosinophilic Asthma Treatment Market Size Growth (2021-2026)
4.4 APAC Eosinophilic Asthma Treatment Market Size Growth (2021-2026)
4.5 Europe Eosinophilic Asthma Treatment Market Size Growth (2021-2026)
4.6 Middle East & Africa Eosinophilic Asthma Treatment Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Eosinophilic Asthma Treatment Market Size by Country (2021-2026)
5.2 Americas Eosinophilic Asthma Treatment Market Size by Type (2021-2026)
5.3 Americas Eosinophilic Asthma Treatment Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Eosinophilic Asthma Treatment Market Size by Region (2021-2026)
6.2 APAC Eosinophilic Asthma Treatment Market Size by Type (2021-2026)
6.3 APAC Eosinophilic Asthma Treatment Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Eosinophilic Asthma Treatment Market Size by Country (2021-2026)
7.2 Europe Eosinophilic Asthma Treatment Market Size by Type (2021-2026)
7.3 Europe Eosinophilic Asthma Treatment Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Eosinophilic Asthma Treatment by Region (2021-2026)
8.2 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Type (2021-2026)
8.3 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL EOSINOPHILIC ASTHMA TREATMENT MARKET FORECAST

10.1 Global Eosinophilic Asthma Treatment Forecast by Region (2027-2032)
  10.1.1 Global Eosinophilic Asthma Treatment Forecast by Region (2027-2032)
  10.1.2 Americas Eosinophilic Asthma Treatment Forecast
  10.1.3 APAC Eosinophilic Asthma Treatment Forecast
  10.1.4 Europe Eosinophilic Asthma Treatment Forecast
  10.1.5 Middle East & Africa Eosinophilic Asthma Treatment Forecast
10.2 Americas Eosinophilic Asthma Treatment Forecast by Country (2027-2032)
  10.2.1 United States Market Eosinophilic Asthma Treatment Forecast
  10.2.2 Canada Market Eosinophilic Asthma Treatment Forecast
  10.2.3 Mexico Market Eosinophilic Asthma Treatment Forecast
  10.2.4 Brazil Market Eosinophilic Asthma Treatment Forecast
10.3 APAC Eosinophilic Asthma Treatment Forecast by Region (2027-2032)
  10.3.1 China Eosinophilic Asthma Treatment Market Forecast
  10.3.2 Japan Market Eosinophilic Asthma Treatment Forecast
  10.3.3 Korea Market Eosinophilic Asthma Treatment Forecast
  10.3.4 Southeast Asia Market Eosinophilic Asthma Treatment Forecast
  10.3.5 India Market Eosinophilic Asthma Treatment Forecast
  10.3.6 Australia Market Eosinophilic Asthma Treatment Forecast
10.4 Europe Eosinophilic Asthma Treatment Forecast by Country (2027-2032)
  10.4.1 Germany Market Eosinophilic Asthma Treatment Forecast
  10.4.2 France Market Eosinophilic Asthma Treatment Forecast
  10.4.3 UK Market Eosinophilic Asthma Treatment Forecast
  10.4.4 Italy Market Eosinophilic Asthma Treatment Forecast
  10.4.5 Russia Market Eosinophilic Asthma Treatment Forecast
10.5 Middle East & Africa Eosinophilic Asthma Treatment Forecast by Region (2027-2032)
  10.5.1 Egypt Market Eosinophilic Asthma Treatment Forecast
  10.5.2 South Africa Market Eosinophilic Asthma Treatment Forecast
  10.5.3 Israel Market Eosinophilic Asthma Treatment Forecast
  10.5.4 Turkey Market Eosinophilic Asthma Treatment Forecast
10.6 Global Eosinophilic Asthma Treatment Forecast by Type (2027-2032)
10.7 Global Eosinophilic Asthma Treatment Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Eosinophilic Asthma Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 AstraZeneca
  11.1.1 AstraZeneca Company Information
  11.1.2 AstraZeneca Eosinophilic Asthma Treatment Product Offered
  11.1.3 AstraZeneca Eosinophilic Asthma Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 AstraZeneca Main Business Overview
  11.1.5 AstraZeneca Latest Developments
11.2 GSK
  11.2.1 GSK Company Information
  11.2.2 GSK Eosinophilic Asthma Treatment Product Offered
  11.2.3 GSK Eosinophilic Asthma Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 GSK Main Business Overview
  11.2.5 GSK Latest Developments
11.3 Genentech (Roche Group) & Novartis
  11.3.1 Genentech (Roche Group) & Novartis Company Information
  11.3.2 Genentech (Roche Group) & Novartis Eosinophilic Asthma Treatment Product Offered
  11.3.3 Genentech (Roche Group) & Novartis Eosinophilic Asthma Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Genentech (Roche Group) & Novartis Main Business Overview
  11.3.5 Genentech (Roche Group) & Novartis Latest Developments
11.4 Regeneron Pharmaceuticals & Sanofi
  11.4.1 Regeneron Pharmaceuticals & Sanofi Company Information
  11.4.2 Regeneron Pharmaceuticals & Sanofi Eosinophilic Asthma Treatment Product Offered
  11.4.3 Regeneron Pharmaceuticals & Sanofi Eosinophilic Asthma Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Regeneron Pharmaceuticals & Sanofi Main Business Overview
  11.4.5 Regeneron Pharmaceuticals & Sanofi Latest Developments
11.5 Teva Pharmaceuticals
  11.5.1 Teva Pharmaceuticals Company Information
  11.5.2 Teva Pharmaceuticals Eosinophilic Asthma Treatment Product Offered
  11.5.3 Teva Pharmaceuticals Eosinophilic Asthma Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Teva Pharmaceuticals Main Business Overview
  11.5.5 Teva Pharmaceuticals Latest Developments
11.6 Amgen
  11.6.1 Amgen Company Information
  11.6.2 Amgen Eosinophilic Asthma Treatment Product Offered
  11.6.3 Amgen Eosinophilic Asthma Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Amgen Main Business Overview
  11.6.5 Amgen Latest Developments
11.7 Sunshine Guojian
  11.7.1 Sunshine Guojian Company Information
  11.7.2 Sunshine Guojian Eosinophilic Asthma Treatment Product Offered
  11.7.3 Sunshine Guojian Eosinophilic Asthma Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Sunshine Guojian Main Business Overview
  11.7.5 Sunshine Guojian Latest Developments
11.8 Hengrui Pharma
  11.8.1 Hengrui Pharma Company Information
  11.8.2 Hengrui Pharma Eosinophilic Asthma Treatment Product Offered
  11.8.3 Hengrui Pharma Eosinophilic Asthma Treatment Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Hengrui Pharma Main Business Overview
  11.8.5 Hengrui Pharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Eosinophilic Asthma Treatment Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Eosinophilic Asthma Treatment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Intravenous Infusion
Table 4. Major Players of Subcutaneous Injection
Table 5. Eosinophilic Asthma Treatment Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Eosinophilic Asthma Treatment Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Eosinophilic Asthma Treatment Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Anti-IL-5
Table 9. Major Players of Anti-IL-5R?
Table 10. Major Players of Anti-IL-4R?
Table 11. Major Players of Anti-TSLP
Table 12. Major Players of Others
Table 13. Eosinophilic Asthma Treatment Market Size CAGR by Target (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Eosinophilic Asthma Treatment Market Size by Target (2021-2026) & ($ millions)
Table 15. Global Eosinophilic Asthma Treatment Market Size Market Share by Target (2021-2026)
Table 16. Major Players of Severe Eosinophilic Asthma
Table 17. Major Players of Moderate-to-Severe Eosinophilic Asthma
Table 18. Major Players of Others
Table 19. Eosinophilic Asthma Treatment Market Size CAGR by Disease Severity (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Eosinophilic Asthma Treatment Market Size by Disease Severity (2021-2026) & ($ millions)
Table 21. Global Eosinophilic Asthma Treatment Market Size Market Share by Disease Severity (2021-2026)
Table 22. Eosinophilic Asthma Treatment Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Eosinophilic Asthma Treatment Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Eosinophilic Asthma Treatment Market Size Market Share by Application (2021-2026)
Table 25. Global Eosinophilic Asthma Treatment Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Eosinophilic Asthma Treatment Revenue Market Share by Player (2021-2026)
Table 27. Eosinophilic Asthma Treatment Key Players Head office and Products Offered
Table 28. Eosinophilic Asthma Treatment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Eosinophilic Asthma Treatment Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Eosinophilic Asthma Treatment Market Size Market Share by Region (2021-2026)
Table 33. Global Eosinophilic Asthma Treatment Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Eosinophilic Asthma Treatment Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Eosinophilic Asthma Treatment Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Eosinophilic Asthma Treatment Market Size Market Share by Country (2021-2026)
Table 37. Americas Eosinophilic Asthma Treatment Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Eosinophilic Asthma Treatment Market Size Market Share by Type (2021-2026)
Table 39. Americas Eosinophilic Asthma Treatment Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Eosinophilic Asthma Treatment Market Size Market Share by Application (2021-2026)
Table 41. APAC Eosinophilic Asthma Treatment Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Eosinophilic Asthma Treatment Market Size Market Share by Region (2021-2026)
Table 43. APAC Eosinophilic Asthma Treatment Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Eosinophilic Asthma Treatment Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Eosinophilic Asthma Treatment Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Eosinophilic Asthma Treatment Market Size Market Share by Country (2021-2026)
Table 47. Europe Eosinophilic Asthma Treatment Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Eosinophilic Asthma Treatment Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Eosinophilic Asthma Treatment Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Eosinophilic Asthma Treatment Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Eosinophilic Asthma Treatment Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Eosinophilic Asthma Treatment
Table 53. Key Market Challenges & Risks of Eosinophilic Asthma Treatment
Table 54. Key Industry Trends of Eosinophilic Asthma Treatment
Table 55. Global Eosinophilic Asthma Treatment Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Eosinophilic Asthma Treatment Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Eosinophilic Asthma Treatment Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Eosinophilic Asthma Treatment Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. AstraZeneca Details, Company Type, Eosinophilic Asthma Treatment Area Served and Its Competitors
Table 60. AstraZeneca Eosinophilic Asthma Treatment Product Offered
Table 61. AstraZeneca Eosinophilic Asthma Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. AstraZeneca Main Business
Table 63. AstraZeneca Latest Developments
Table 64. GSK Details, Company Type, Eosinophilic Asthma Treatment Area Served and Its Competitors
Table 65. GSK Eosinophilic Asthma Treatment Product Offered
Table 66. GSK Eosinophilic Asthma Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. GSK Main Business
Table 68. GSK Latest Developments
Table 69. Genentech (Roche Group) & Novartis Details, Company Type, Eosinophilic Asthma Treatment Area Served and Its Competitors
Table 70. Genentech (Roche Group) & Novartis Eosinophilic Asthma Treatment Product Offered
Table 71. Genentech (Roche Group) & Novartis Eosinophilic Asthma Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Genentech (Roche Group) & Novartis Main Business
Table 73. Genentech (Roche Group) & Novartis Latest Developments
Table 74. Regeneron Pharmaceuticals & Sanofi Details, Company Type, Eosinophilic Asthma Treatment Area Served and Its Competitors
Table 75. Regeneron Pharmaceuticals & Sanofi Eosinophilic Asthma Treatment Product Offered
Table 76. Regeneron Pharmaceuticals & Sanofi Eosinophilic Asthma Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Regeneron Pharmaceuticals & Sanofi Main Business
Table 78. Regeneron Pharmaceuticals & Sanofi Latest Developments
Table 79. Teva Pharmaceuticals Details, Company Type, Eosinophilic Asthma Treatment Area Served and Its Competitors
Table 80. Teva Pharmaceuticals Eosinophilic Asthma Treatment Product Offered
Table 81. Teva Pharmaceuticals Eosinophilic Asthma Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Teva Pharmaceuticals Main Business
Table 83. Teva Pharmaceuticals Latest Developments
Table 84. Amgen Details, Company Type, Eosinophilic Asthma Treatment Area Served and Its Competitors
Table 85. Amgen Eosinophilic Asthma Treatment Product Offered
Table 86. Amgen Eosinophilic Asthma Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Amgen Main Business
Table 88. Amgen Latest Developments
Table 89. Sunshine Guojian Details, Company Type, Eosinophilic Asthma Treatment Area Served and Its Competitors
Table 90. Sunshine Guojian Eosinophilic Asthma Treatment Product Offered
Table 91. Sunshine Guojian Eosinophilic Asthma Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Sunshine Guojian Main Business
Table 93. Sunshine Guojian Latest Developments
Table 94. Hengrui Pharma Details, Company Type, Eosinophilic Asthma Treatment Area Served and Its Competitors
Table 95. Hengrui Pharma Eosinophilic Asthma Treatment Product Offered
Table 96. Hengrui Pharma Eosinophilic Asthma Treatment Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. Hengrui Pharma Main Business
Table 98. Hengrui Pharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Eosinophilic Asthma Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Eosinophilic Asthma Treatment Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Eosinophilic Asthma Treatment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Eosinophilic Asthma Treatment Sales Market Share by Country/Region (2025)
Figure 8. Eosinophilic Asthma Treatment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Eosinophilic Asthma Treatment Market Size Market Share by Type in 2025
Figure 10. Global Eosinophilic Asthma Treatment Market Size Market Share by Target in 2025
Figure 11. Global Eosinophilic Asthma Treatment Market Size Market Share by Disease Severity in 2025
Figure 12. Eosinophilic Asthma Treatment in Children
Figure 13. Global Eosinophilic Asthma Treatment Market: Children (2021-2026) & ($ millions)
Figure 14. Eosinophilic Asthma Treatment in Adults
Figure 15. Global Eosinophilic Asthma Treatment Market: Adults (2021-2026) & ($ millions)
Figure 16. Eosinophilic Asthma Treatment in Teenagers
Figure 17. Global Eosinophilic Asthma Treatment Market: Teenagers (2021-2026) & ($ millions)
Figure 18. Global Eosinophilic Asthma Treatment Market Size Market Share by Application in 2025
Figure 19. Global Eosinophilic Asthma Treatment Revenue Market Share by Player in 2025
Figure 20. Global Eosinophilic Asthma Treatment Market Size Market Share by Region (2021-2026)
Figure 21. Americas Eosinophilic Asthma Treatment Market Size 2021-2026 ($ millions)
Figure 22. APAC Eosinophilic Asthma Treatment Market Size 2021-2026 ($ millions)
Figure 23. Europe Eosinophilic Asthma Treatment Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Eosinophilic Asthma Treatment Market Size 2021-2026 ($ millions)
Figure 25. Americas Eosinophilic Asthma Treatment Value Market Share by Country in 2025
Figure 26. United States Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Eosinophilic Asthma Treatment Market Size Market Share by Region in 2025
Figure 31. APAC Eosinophilic Asthma Treatment Market Size Market Share by Type (2021-2026)
Figure 32. APAC Eosinophilic Asthma Treatment Market Size Market Share by Application (2021-2026)
Figure 33. China Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 37. India Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Eosinophilic Asthma Treatment Market Size Market Share by Country in 2025
Figure 40. Europe Eosinophilic Asthma Treatment Market Size Market Share by Type (2021-2026)
Figure 41. Europe Eosinophilic Asthma Treatment Market Size Market Share by Application (2021-2026)
Figure 42. Germany Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 43. France Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Eosinophilic Asthma Treatment Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Eosinophilic Asthma Treatment Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Eosinophilic Asthma Treatment Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Eosinophilic Asthma Treatment Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 56. APAC Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 57. Europe Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 59. United States Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 60. Canada Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 61. Mexico Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 62. Brazil Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 63. China Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 64. Japan Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 65. Korea Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 67. India Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 68. Australia Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 69. Germany Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 70. France Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 71. UK Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 72. Italy Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 73. Russia Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 74. Egypt Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 75. South Africa Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 76. Israel Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 77. Turkey Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)
Figure 78. Global Eosinophilic Asthma Treatment Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Eosinophilic Asthma Treatment Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Eosinophilic Asthma Treatment Market Size 2027-2032 ($ millions)